Clinical Data

• AcQMap — informed therapy in retreatment of Persistent AF patients (N = 106)
• Recover AF study is complete and the results are published

• AcQBlate Force Sensing Ablation System used for the treatment of typical atrial flutter in a US Investigational Device Exemption (IDE) study (N=100).
• AcQForce Flutter currently enrolling. NCT04658940

CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device
and is limited by United States law to investigational use.

• AcQBlate Force Sensing Ablation System used for the treatment of typical atrial flutter in a European and United Kingdom post-market study (N=50).
• AcQForce Flutter-EU currently enrolling. NCT04657055

CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device
and is limited by United States law to investigational use.

• AcQMap System US Registry – informed therapy in de novo and retreatment AF patients with contact and non-contact technologies (N=500).
• AcQMap DISCOVER Registry-US currently enrolling. NCT04431544

• AcQMap System Global Registry – informed therapy in de novo and retreatment AF patients with contact and non-contact technologies (N=500).
• AcQMap DISCOVER Registry-EU currently enrolling. NCT03893331

• Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER AF)
• AcQMap — informed therapy in de novo Persistent AF patients (N = 129)

• Dipole Density Right (and left) Atrial Mapping and Assessment of Therapy in Complex Supraventricular Tachycardia (DDRAMATIC-SVT)
• AcQMap proof of concept compared to existing technologies in Persistent and Long-Standing Persistent AF patients (N = 85)
• DDRAMATIC-SVT study complete

• Initial experience for safety (N = 12)
• FIRST IN MAN study complete